
Patent Owners Starting to Get the Last Word at the PTAB
Patent Owner Sur-Replies on the Uptick Back in June of 2016, the Federal Circuit issued its opinion in Genzyme Therapeutic Products LP v. BioMarin Pharmaceutical Inc.( here ). At the time I explained that Genzyme was a game-changer . This was because it…

